Dennis J. Wright
Chief Tech/Sci/R&D Officer bei CLINUVEL PHARMACEUTICALS LIMITED
Vermögen: 1 Mio $ am 31.03.2024
Profil
Dennis J.
Wright is currently the Chief Scientific Officer at Clinuvel Pharmaceuticals Ltd.
He previously worked as the Manager-Global Pharmacovigilance at Mayne Pharma Ltd.
Dr. Wright completed his undergraduate and graduate degrees at The University of Sydney.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
15.08.2023 | 156 874 ( 0,31% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von Dennis J. Wright
Unternehmen | Position | Beginn |
---|---|---|
CLINUVEL PHARMACEUTICALS LIMITED | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Dennis J. Wright
Unternehmen | Position | Ende |
---|---|---|
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | General Counsel | - |
Ausbildung von Dennis J. Wright
The University of Sydney | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CLINUVEL PHARMACEUTICALS LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | Health Technology |